Apolipoprotein e genotype and lipid and lipoprotein levels in dementia

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 2, 2000, Pages 70-73

  Wehr, H ^a,b   Parnowski, T ^a   Puzynski S ^a   Bednarska Makaruk, M ^a   Bisko, M ^a   Kotapka Minc, S ^a   Rodo, M ^a   Wolkowska M ^b  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Apolipoprotein E genotype; Dementia; Lipids

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034000722     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017217     Document Type: Article

References (21)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein type E allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
2. Strittmatter WJ, Roses AD: Apoprotein E and Alzheimer disease. Annu Rev Neurosci 1996; 19:53-77.
3. Sarochan M, Foestl H, Sattel H, Zerfass R, Czech C, Beyreuther K: Apolipoprotein genotype does not promote the clinical progression of manifest Alzheimer disease. Dementia 1996; 7:120.
4. Landen M, Thorsell A, Wallin A, Blennow K: The apolipoprotein E allele ε4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer disease. J Neurol Neurosurg Psychiatry 1996; 61:352-356.
5. Editorial: Apolipoprotein E: A review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol Med 1995;25:223-229.
6. Pickering-Brown SM, Mann DMA, Bourks JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F: Apolipoprotein E4 and Alzheimer disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 1994;343:1155.
7. Robitaille N, Cormier G, Couture R, Bouthiller D, Davignon J, Perousse I: Apolipoprotein polymorphism in a French-Canadian population of northeastern Quebec - Allele frequencies and effects on blood lipid and lipoprotein levels. Hum Biol 1966;68:357-370.
8. Stengard JH, Pekkanen J, Ehnholm C, Nissinen A, Sing CP: Genotypes with the apolipoprotein ε4 are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Gen 1996;97:677-684.
9. Castano EM, Prelli F, Wisniewski T, Goła̧bek A, Kumar RA, Soto C, Frangione B: Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem J 1995;306:599-604.
10. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GVW: Differential binding of apolipoprotein isoforms to tau and other cytoskeletal proteins. Exp Neurol 1996; 138:252-260.
11. Mahley RW: Expanding roles for apolipoprotein E in health and disease. 11th International Symposium on Atherosclerosis, Paris, Oct 1997.
12. McKeith IG, Fairbairn AF, Perry RH, Thompson P: The clinical diagnosis and misdiagnosis of senile dementia of Levy body type (SDLT). Br J Psychiatry 1944;165:324-332.
13. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548.
14. Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty BA, Beiser A, Wolf PA: Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study. Neurology 1996;46: 672-673.
15. Asherov A, Veshehev J, Korczyn AD: Apo-ε4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1996;10:189-191.
16. Isoe K, Urakami K, Sato K, Takahashi K: Apolipoprotcin E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996;93:133-137.
17. Stengard JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A: Apolipoprotein E polymorphism, Alzheimer disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995;92:297-298.
18. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-354.
19. Sulkava R, Kainulainen K, Verkkoniemi A, Niinisto I, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K: ApoE alleles in Alzheimer disease and vascular dementia in a population aged 85+. Neurobiol Aging 1996;17: 373-376.
20. Fifth International Conference on Alzheimer Disease and Related Disorders, Osaka 1996: Alzheimer disease and vascular dementia: Is there a link? The News 1996.
21. Rywik S, Broda G: Program POL-MONICA Warszawa cz. V: Kompleksowa ocena stanu zdrowia ludności Warszawy w roku 1993 i jego zmian w latach 1984-1993 Warszawa 1995.